Home/Sentrimed/William Ragatz

WR

William Ragatz

President and CEO

Therapeutic Areas

Sentrimed Pipeline

Drug	Indication	Phase
Podoplanin Inhibitor / Contact Normalization Therapy	Cancer (tumor-agnostic)	Phase 1

Leadership Team at Sentrimed

Dr. Gary S. Goldberg, PhD

Founder and Chief Science Officer

Dr. Jack Goldberg, MD

Chief Medical Officer

View full Sentrimed profile